Predictive Oncology Inc. (POAI)

Market Cap	4.43M
Revenue (ttm)	1.75M
Net Income (ttm)	-14.04M
Shares Out	6.67M
EPS (ttm)	-3.34
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	128,711
Open	0.695
Previous Close	0.677
Day's Range	0.654 - 0.705
52-Week Range	0.550 - 3.760
Beta	1.13
Analysts	Strong Buy
Price Target	3.00 (+351.67%)
Earnings Date	Nov 12, 2024

About POAI

Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies. It operates through three segments: Pittsburgh, Birmingham, and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of approximately 150,000 tumor samples and creates proprietary 3D culture models used in drug development. The Birmingham segment offers contract services and research focused on solubility improvemen...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2002
• Employees: 35
• Stock Exchange: NASDAQ
• Ticker Symbol: POAI
• Website: https://www.predictive-oncology.com

Financial Performance

In 2023, Predictive Oncology's revenue was $1.78 million, an increase of 18.24% compared to the previous year's $1.51 million. Losses were -$13.98 million, -45.67% less than in 2022.

Analyst Forecast

According to one analyst, the rating for POAI stock is "Strong Buy" and the 12-month stock price forecast is $3.0.

Price Target

$3.0

(351.67% upside)

Analyst Consensus: Strong Buy